ADNI data is made available to researchers around the world. As such, there are many active research projects accessing and applying the shared ADNI data. To further encourage Alzheimer’s disease research collaboration, and to help prevent duplicate efforts, the list below shows the specific research focus of the active ADNI investigations. This information is requested annually as a requirement for data access.
| Principal Investigator | |
| Principal Investigator's Name: | Kaori Ito |
| Institution: | Pfizer Inc |
| Department: | Pharmacometrics |
| Country: | United States of America |
| Proposed Analysis: | develop PKPD model for ADAS-cog to explore the placebo responce vs. drug effect |
| Additional Investigators | |
| Investigator's Name: | James Rogers |
| Proposed Analysis: | Simultaneous Modeling of Patient-level and Summary-level Data to Describe Progression of Alzheimer’s Disease |